digital marketing strategy implementation practice pdf 7e7744709

🔥+ digital marketing strategy implementation practice pdf 7e7744709 06 Jun 2020 {2. Brush your pet hair for smooth look. 3. Remove the loose fur, dust and dirt from your pets. 4. Provide comfortable ... Specifications: Type: Pet Grooming Glove.... ever wanted to know about the 16:8 intermittent fasting diet Prevention Health ... placebo controlled trial in patients with type 2 diabetes, metformin treatment ... McCafé Salads Snacks & Sides catName Go back to categories x.name {x.

digital marketing strategy implementation practice pdf 7e7744709 More often than not, Type 1 Diabetics have developed the autoimmune disease before the age of 40. Type 1 Diabetes is often referred to as Juvenile Diabetes and ...

classes of diabetic medication
Advertisement
 
for 1 last update 06 Jun 2020   
 

CYNTHIA M. RIPSIN, MD, MS, MPH; HELEN KANG, MD; and RANDALL the 1 last update 06 Jun 2020 J. URBAN, MD, University of Texas Medical Branch, Galveston, TexasCYNTHIA M. RIPSIN, MD, MS, MPH; HELEN KANG, MD; and RANDALL J. URBAN, MD, University of Texas Medical Branch, Galveston, Texas

Am Fam Physician. 2009 Jan 1;79(1):29-36.

  A more recent article on type 2 diabetes mellitus is available.

  Patient information: See related handout on lifestyle changes to manage type 2 diabetes, written by the authors of this article.

Evidence-based guidelines for the treatment of type 2 diabetes mellitus focus on three areas: intensive lifestyle intervention that includes at least 150 minutes per week of physical activity, weight loss with an initial goal of 7 percent of baseline weight, and a low-fat, reduced-calorie diet; aggressive management of cardiovascular risk factors (i.e., hypertension, dyslipidemia, and microalbuminuria) with the use of aspirin, statins, and angiotensin-converting enzyme inhibitors; and normalization of blood glucose levels (hemoglobin A1C level less than 7 percent). Insulin resistance, decreased insulin secretion, and increased hepatic glucose output are the hallmarks of type 2 diabetes, and each class of medication targets one or more of these defects. Metformin, which decreases hepatic glucose output and sensitizes peripheral tissues to insulin, has been shown to decrease mortality rates in patients with type 2 diabetes and is considered a first-line agent. Other medications include sulfonylureas and nonsulfonylurea secretagogues, alpha glucosidase inhibitors, and thiazolidinediones. Insulin can be used acutely in patients newly diagnosed with type 2 diabetes to normalize blood glucose, or it can be added to a regimen of oral medication to improve glycemic control. Except in patients taking multiple insulin injections, home monitoring of blood glucose levels has questionable utility, especially in relatively well-controlled patients. Its use should be tailored to the needs of the individual patient.

Type 2 diabetes mellitus, the sixth leading cause of death in the United States, is directly responsible for more than 73,000 deaths annually and is a contributing factor in more than 220,000 deaths.1 It is the leading cause of kidney failure and new cases of blindness in adults,1 and it is a significant cause of lost workforce productivity.2 More than 20 million Americans have diabetes; 6 million of these are undiagnosed.1 Ethnic and racial minorities are disproportionately affected.1  Derangement of glucose homeostasis and the eventual development of diabetes is a multifactorial process involving genetics, ethnic and racial heritage, and environmental factors. Although the precise interplay of these factors is not yet fully understood, long-term trials have provided evidence to support aggressive efforts to prevent and manage this disease (digital marketing strategy implementation practice pdf 7e7744709 nature journal (🔴 mellitus icd 10) | digital marketing strategy implementation practice pdf 7e7744709 wild ricehow to digital marketing strategy implementation practice pdf 7e7744709 for Table 1).36

View/Print Table

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendationsEvidence ratingReferences

Patients with impaired glucose tolerance should be provided with counseling and instruction for weight loss and physical activity.

A

6, 8

Metformin (Glucophage) is the only medication proven to reduce mortality rates in patients with type 2 diabetes.

A

5

Acarbose (Precose) seems to reduce the risk of cardiovascular disease events.

B

13, 17 1921

When adding insulin to a regimen of oral medication, oral agents should be continued initially. Long-acting insulin should be used initially, typically at a dosage of 10 units per day or 0.17 to 0.5 units per kg per day, and titrated in increments of two units approximately every three days.

C

14, 24


A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.xml.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendationsEvidence ratingReferences

Patients with impaired glucose tolerance should be provided with counseling and instruction for weight loss and physical activity.

A

6 for 1 last update 06 Jun 2020 , , 8

digital marketing strategy implementation practice pdf 7e7744709 lunch (⭐️ glut4) | digital marketing strategy implementation practice pdf 7e7744709 reddithow to digital marketing strategy implementation practice pdf 7e7744709 for Metformin (Glucophage) is the only medication proven to reduce mortality rates in patients with type 2 diabetes.

the 1 last update 06 Jun 2020 AA

55

Acarbose (Precose) seems to reduce the risk of cardiovascular disease events.

B

13, 17 19digital marketing strategy implementation practice pdf 7e7744709 mellitus definition (⭐️ etiology) | digital marketing strategy implementation practice pdf 7e7744709 crampinghow to digital marketing strategy implementation practice pdf 7e7744709 for –21

When adding insulin to a regimen of oral medication, oral agents should be continued initially. Long-acting insulin should be used initially, typically at a dosage of 10 units per day or 0.17 to 0.5 units per kg per day, and titrated in increments of two units approximately every three days.

C

14, 24


A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.xml.

View/Print Table

Table 1.

Major Trials That Form the Basis for Treatment Rationale for Type 2 Diabetes Mellitus

TrialYears (average duration) for 1 last update 06 Jun 2020 DesignDesignParticipantsInterventionResultsdigital marketing strategy implementation practice pdf 7e7744709 and obesity (⭐️ hands) | digital marketing strategy implementation practice pdf 7e7744709 mellitus naturehow to digital marketing strategy implementation practice pdf 7e7744709 for Clinical contributions

UKPDS3 for 1 last update 06 Jun 2020 ,,4

1977 to 1991 (10 years)

digital marketing strategy implementation practice pdf 7e7744709 treatment aafp (⭐️ josh axe) | digital marketing strategy implementation practice pdf 7e7744709 pathohow to digital marketing strategy implementation practice pdf 7e7744709 for Multicenter for 1 last update 06 Jun 2020 randomized controlled trialMulticenter randomized controlled trial

3,867 Newly diagnosed with type 2 diabetes; average age, 54 years

Sulfonylureas, insulin, or dietary intervention

Treatment reduced risk of microvascular end points (e.g., need for retinal photocoagulation) by 25 percent (95% CI, 7 to 40 percent) Reduced mortality rates with blood pressure and lipid control

digital marketing strategy implementation practice pdf 7e7744709 and hypothyroidism (👍 compared to type 1) | digital marketing strategy implementation practice pdf 7e7744709 essayhow to digital marketing strategy implementation practice pdf 7e7744709 for Blood pressure and lipid control greatly reduce cardiovascular mortality rates in patients with diabetes Tight blood glucose control reduces retinal microvascular complications The highest annual incidence of major hypoglycemic events was 2.3 percent and occurred in patients on insulin therapy

UKPDS (second arm within the larger trial)5

1977 to 1991 (10.7 years)

Randomized embedded trial

753 Newly diagnosed with type 2 diabetes; BMI at randomization > 120 percent of ideal

Metformin (Glucophage) or dietary intervention Secondary analysis compared metformin with insulin and sulfonylureas Another secondary analysis compared the addition the 1 last update 06 Jun 2020 of metformin to sulfonylureas when participants failed treatment with sulfonylureasMetformin (Glucophage) or dietary intervention Secondary analysis compared metformin with insulin and sulfonylureas Another secondary analysis compared the addition of metformin to sulfonylureas when participants failed treatment with sulfonylureas

digital marketing strategy implementation practice pdf 7e7744709 olives (🔴 wild rice) | digital marketing strategy implementation practice pdf 7e7744709 nurse teachinghow to digital marketing strategy implementation practice pdf 7e7744709 for 36 percent reduction in all-cause mortality (P = .011) and 42 percent reduction in diabetes-related death (P = .017) with use of metformin compared with conventional therapy

Metformin should be the drug of choice in the 1 last update 06 Jun 2020 patients with type 2 diabetes, particularly in obese patientsMetformin should be the drug of choice in patients with type 2 diabetes, particularly in obese patients

Diabetes Prevention Program6

1996 to 1999 (2.8 years)

Multicenter randomized controlled trial

3,234 At least 25 years of age (mean, 51 years) with BMI ≥ 24 kg per m2 (mean, 34 kg per m2), fasting glucose level of 95 to 125 mg per dL (5.30 to 6.95 mmol per L), and glucose level of 140 to 199 mg per dL (7.75 to 11.05 mmol per L) two hours post-glucose load

Metformin, placebo, or intensive lifestyle intervention, which included 150 minutes of weekly exercise and a goal of 7 percent weight loss

Average weight loss:

Incidence of diabetes:

Placebo: 0.1 kg

digital marketing strategy implementation practice pdf 7e7744709 sugar level (🔥 good food) | digital marketing strategy implementation practice pdf 7e7744709 in hindihow to digital marketing strategy implementation practice pdf 7e7744709 for Placebo: 11.0 the 1 last update 06 Jun 2020 cases per 100 person-yearsPlacebo: 11.0 cases per 100 person-years

Metformin: 2.1 kg

Metformin: 7.8 cases per 100 person-years

Lifestyle: 5.6 kg

Lifestyle: 4.8 cases per 100 person-years

Reduction in daily energy intake (in for 1 last update 06 Jun 2020 kcals):Reduction in daily energy intake (in kcals):

Number needed to treat to prevent one new case of diabetes in three years:

Placebo: 249 ± 27

Metformin: 296 ± 23

for 1 last update 06 Jun 2020

digital marketing strategy implementation practice pdf 7e7744709 immune system (☑ good foods to eat) | digital marketing strategy implementation practice pdf 7e7744709 kidney painhow to digital marketing strategy implementation practice pdf 7e7744709 for Metformin: 13.9

Lifestyle: 450 ± 26

Lifestyle: 6.9


BMI = body mass index; CI = confidence interval; UKPDS = United Kingdom Prospective Diabetes for 1 last update 06 Jun 2020 StudyBMI = body mass index; CI = confidence interval; UKPDS = United Kingdom Prospective Diabetes Study.

Information from references 3 through 6.Information from references 3 through 6.

Table 1.

Major Trials That Form the Basis for Treatment Rationale for Type 2 Diabetes Mellitus

TrialYears (average duration)DesignParticipantsInterventiondigital marketing strategy implementation practice pdf 7e7744709 knowledge portal (⭐️ dinner) | digital marketing strategy implementation practice pdf 7e7744709 metforminhow to digital marketing strategy implementation practice pdf 7e7744709 for Resultsdigital marketing strategy implementation practice pdf 7e7744709 metformin (⭐️ video) | digital marketing strategy implementation practice pdf 7e7744709 immune systemhow to digital marketing strategy implementation practice pdf 7e7744709 for Clinical contributions

UKPDS3,4

1977 to 1991 (10 for 1 last update 06 Jun 2020 years)1977 to 1991 (10 years)

Multicenter randomized controlled trial

3,867 Newly diagnosed with type for 1 last update 06 Jun 2020 2 diabetes; average age, 54 years3,867 Newly diagnosed with type 2 diabetes; average age, 54 years

Sulfonylureas, insulin, or dietary intervention

Treatment reduced risk of microvascular end points (e.g., need for retinal photocoagulation) by 25 percent (95% CI, 7 to 40 percent) Reduced mortality rates with blood pressure and lipid control

Blood pressure and lipid control greatly reduce cardiovascular mortality rates in patients with diabetes Tight blood glucose control reduces retinal microvascular complications for 1 last update 06 Jun 2020 The highest annual incidence of major hypoglycemic events was 2.3 percent and occurred in patients on insulin therapy

UKPDS (second arm within the larger trial)5

1977 to 1991 (10.7 years)

Randomized embedded trial

753 Newly diagnosed with type 2 diabetes; BMI at randomization > 120 percent of ideal

Metformin (Glucophage) or dietary intervention Secondary analysis compared metformin with insulin and sulfonylureas Another secondary analysis compared the addition of metformin to sulfonylureas when participants failed treatment with sulfonylureas

36 percent reduction in all-cause mortality (P = .011) and 42 percent reduction in diabetes-related death (P = .017) with use of metformin compared with conventional therapy

Metformin should be the drug of choice in patients with type 2 diabetes, particularly in obese patients

Diabetes Prevention Program6

1996 to 1999 (2.8 years)

Multicenter randomized controlled trial

3,234 At least 25 years of age (mean, 51 years) with BMI ≥ 24 kg per m2 (mean, 34 kg per m2), fasting glucose level of 95 to 125 mg per dL (5.30 to 6.95 mmol per L), and glucose level of 140 to 199 mg per dL (7.75 to 11.05 mmol per L) two hours post-glucose load

Metformin, placebo, or intensive lifestyle intervention, which included 150 minutes of weekly exercise and a goal of 7 percent weight loss

Average weight loss:

Incidence of diabetes:

Placebo: 0.1 kg

digital marketing strategy implementation practice pdf 7e7744709 origin (☑ exercise) | digital marketing strategy implementation practice pdf 7e7744709 food planhow to digital marketing strategy implementation practice pdf 7e7744709 for

digital marketing strategy implementation practice pdf 7e7744709 in hindi (⭐️ treatment guidelines) | digital marketing strategy implementation practice pdf 7e7744709 glucagonhow to digital marketing strategy implementation practice pdf 7e7744709 for Placebo: 11.0 cases per 100 person-years

Metformin: 2.1 kg

digital marketing strategy implementation practice pdf 7e7744709 origin (☑ obesity) | digital marketing strategy implementation practice pdf 7e7744709 new zealand statisticshow to digital marketing strategy implementation practice pdf 7e7744709 for

Metformin: 7.8 cases per 100 person-years

Lifestyle: 5.6 kg

Lifestyle: 4.8 cases per 100 person-years

Reduction in daily energy intake (in kcals):

Number needed to treat to prevent one new case of diabetes in three years:

Placebo: 249 ± 27

Metformin: 296 ± 23

Metformin: 13.9

Lifestyle: 450 ± 26

digital marketing strategy implementation practice pdf 7e7744709 low blood sugar (👍 risk factors) | digital marketing strategy implementation practice pdf 7e7744709 natural remedyhow to digital marketing strategy implementation practice pdf 7e7744709 for

Lifestyle: 6.9


digital marketing strategy implementation practice pdf 7e7744709 leg pain (👍 Treatments) | digital marketing strategy implementation practice pdf 7e7744709 patchhow to digital marketing strategy implementation practice pdf 7e7744709 for BMI = body mass index; CI = confidence interval; UKPDS = United Kingdom Prospective Diabetes Study.

digital marketing strategy implementation practice pdf 7e7744709 ribbon (👍 jokes) | digital marketing strategy implementation practice pdf 7e7744709 autoimmunehow to digital marketing strategy implementation practice pdf 7e7744709 for Information from references 3 through 6.

Management of Type 2 Diabetes

Evidence-based guidelines the 1 last update 06 Jun 2020 for the comprehensive management of diabetes focus primarily on lifestyle changes, management of cardiovascular disease risk factors, and management of blood glucose levels.7Evidence-based guidelines for the comprehensive management of diabetes focus primarily on lifestyle changes, management of cardiovascular disease risk factors, and management of blood glucose levels.7

LIFESTYLE CHANGES

digital marketing strategy implementation practice pdf 7e7744709 born (👍 paper) | digital marketing strategy implementation practice pdf 7e7744709 insulin pumphow to digital marketing strategy implementation practice pdf 7e7744709 for Lifestyle modification can help patients lose weight and reduces the incidence of type 2 diabetes in at-risk patients.8 One large study compared usual care with an intensive lifestyle intervention.6 Although only 38 percent of participants achieved and maintained the weight loss goal of 7 percent of baseline body weight, the incidence of type 2 diabetes was reduced by 58 percent. To prevent one new case of diabetes in three years, 6.9 persons would need to undergo intensive lifestyle intervention.6 Lifestyle changes were much more effective than metformin (Glucophage) therapy. In a review of 14 trials testing exercise interventions in participants with type 2 diabetes, hemoglobin A1C levels were reduced by 0.6 percent, and triglyceride levels and visceral adiposity were decreased independent of weight loss.9 These results underscore the importance of reinforcing lifestyle goals with every patient at every visit, even if weight loss falls short of expectations.

MANAGEMENT OF CARDIOVASCULAR DISEASE RISK FACTORS

Multifactorial interventions to manage cardiovascular disease risk factors (i.e., blood pressure, cholesterol, microalbuminuria) in patients with type 2 diabetes have been shown in well-designed clinical trials to decrease mortality rates.10 Daily low-dose aspirin is recommended for patients with type 2 diabetes and coronary artery disease (CAD), those older than 40 years, and those who have additional risk factors for cardio-vascular disease (e.g., family history of cardiovascular disease, hypertension, smoking, dyslipidemia, albuminuria).7 Statins are recommended for patients with type 2 diabetes and CAD, and for patients with diabetes without CAD who are older than 40 years and have one other cardiovascular disease risk factor.7 Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are mainstays of treatment for patients with micro- or macroalbuminuria.7

MANAGEMENT OF BLOOD GLUCOSE LEVELS

Insulin resistance, decreased insulin secretion, and increased hepatic glucose output are the hallmarks of type 2 diabetes. Medications target one or more of these defects (Table 2).1113 Average absolute reductions in A1C for each class of medication range from 0.5 to 1.0 percent for exenatide (Byetta), pramlintide (Symlin), and alpha-glucosidase inhibitors to 1 to 2.5 percent for sulfonylureas and metformin.14 Reviews have reported that mono-therapy with any oral hypoglycemic agent is superior to dietary management for 1 last update 06 Jun 2020 or placebo in reducing A1C values, but the studies are so heterogeneous that the expected A1C reduction attributed to any class of medication should be interpreted with caution.15,16 For example, six trials that evaluated sulfonylureas for an average of 16 weeks reported mean A1C reductions of 1.8 percent (range, 1 to 2.5 percent),15 whereas the 10-year United Kingdom Prospective Diabetes Study reported an A1C reduction of 0.9 percent with sulfonylureas.3 This suggests that short-term studies may not accurately reflect long-term results. It is also critical to remember that the goal of treatment is not only to reduce A1C levels, but also to prevent premature mortality and morbidity. Not all agents have been proven to achieve this goal.Insulin resistance, decreased insulin secretion, and increased hepatic glucose output are the hallmarks of type 2 diabetes. Medications target one or more of these defects (Table 2).1113 Average absolute reductions in A1C for each class of medication range from 0.5 to 1.0 percent for exenatide (Byetta), pramlintide (Symlin), and alpha-glucosidase inhibitors to 1 to 2.5 percent for sulfonylureas and metformin.14 Reviews have reported that mono-therapy with any oral hypoglycemic agent is superior to dietary management or placebo in reducing A1C values, but the studies are so heterogeneous that the expected A1C reduction attributed to any class of medication should be interpreted with caution.15,16 For example, six trials that evaluated sulfonylureas for an average of 16 weeks reported mean A1C reductions of 1.8 percent (range, 1 to 2.5 percent),15 whereas the 10-year United Kingdom Prospective Diabetes Study reported an A1C reduction of 0.9 percent with sulfonylureas.3 This suggests that short-term studies may not accurately reflect long-term results. It is also critical to remember that the goal of treatment is not only to reduce A1C levels, but also to prevent premature mortality and morbidity. Not all agents have been proven to achieve this goal.

View/Print Table

Table 2.

Medications Used to Manage Blood Glucose in Patients with Type 2 Diabetes Mellitus

digital marketing strategy implementation practice pdf 7e7744709 fasting (☑ treatment without medication) | digital marketing strategy implementation practice pdf 7e7744709 take insulinhow to digital marketing strategy implementation practice pdf 7e7744709 for Classdigital marketing strategy implementation practice pdf 7e7744709 home remedies for (🔴 home remedies) | digital marketing strategy implementation practice pdf 7e7744709 variationhow to digital marketing strategy implementation practice pdf 7e7744709 for for 1 last update 06 Jun 2020 DrugDrugPotential side effectsContraindicationsdigital marketing strategy implementation practice pdf 7e7744709 soda (🔴 virus) | digital marketing strategy implementation practice pdf 7e7744709 doctor near mehow to digital marketing strategy implementation practice pdf 7e7744709 for CommentsRelative cost*

Alpha glucosidase inhibitors

Acarbose (Precose) Miglitol (Glyset)

Flatulence; abdominal pain; diarrhea

digital marketing strategy implementation practice pdf 7e7744709 coronavirus risk (☑ mellitus nature reviews) | digital marketing strategy implementation practice pdf 7e7744709 yeast infectionshow to digital marketing strategy implementation practice pdf 7e7744709 for —

To reverse hypoglycemia (usually only in setting of combination therapy), treat with oral glucose, not sucrose

$$

Amylin analogues

the 1 last update 06 Jun 2020 Pramlintide (Symlin)Pramlintide (Symlin)

Nausea and vomiting; anorexia; headache

Gastroparesis; lack of awareness of hypoglycemia; A1C > 9 percent

Severe hypoglycemia can occur, especially with coadministration of insulin; injectable medication; reduce insulin dose by 50 percent when initiating therapy

$$

Biguanides

Metformin (Glucophage)

Nausea; diarrhea; flatulence

Renal insufficiency (discontinue if creatinine level ≥ 1.4 in women or ≥ 1.5 in men); conditions that predispose to acidosis (e.g., liver disease, hypoxemia, sepsis); discontinue during acute illness and before radiographic procedures requiring intravenous dye (may restart 48 hours after procedure if serum creatinine levels are unchanged)

Decreases circulating androgen levels and increases rates of ovulation in women with polycystic ovarian syndrome; modest weight loss may occur; pregnancy category B based on animal studies but not well-studied in pregnant women

$†

Incretin enhancers

Saxagliptin (Onglyza)‡ Sitagliptin (Januvia)

Nausea and vomiting

Adjust dosage in patients with renal impairment

digital marketing strategy implementation practice pdf 7e7744709 keto diet (☑ patch) | digital marketing strategy implementation practice pdf 7e7744709 questionnairehow to digital marketing strategy implementation practice pdf 7e7744709 for NA

Incretin mimetics

digital marketing strategy implementation practice pdf 7e7744709 herpes (👍 vision) | digital marketing strategy implementation practice pdf 7e7744709 reddithow to digital marketing strategy implementation practice pdf 7e7744709 for Exenatide (Byetta)

Nausea and vomiting; diarrhea; dizziness

Not recommended in patients with severe renal disease (creatinine clearance < 30 mL per minute)

Injectable medication; modest weight loss may occur

$$$$

Insulin for 1 last update 06 Jun 2020 secretagogues: sulfonylureasInsulin secretagogues: sulfonylureas

Chlorpropamide (Diabinese)§

Hypoglycemia; weight gain Glimepiride (Amaryl) Glipizide (Glucotrol) Glyburide (Micronase)digital marketing strategy implementation practice pdf 7e7744709 wild rice (👍 symptoms in children) | digital marketing strategy implementation practice pdf 7e7744709 permanentlyhow to digital marketing strategy implementation practice pdf 7e7744709 for Tolazamide (Tolinase)§ Tolbutamide (Orinase)§

$†

Insulin secretagogues: nonsulfonylureas

the 1 last update 06 Jun 2020 Nateglinide (Starlix)Nateglinide (Starlix)

Hypoglycemiadigital marketing strategy implementation practice pdf 7e7744709 home remedies (⭐️ journal) | digital marketing strategy implementation practice pdf 7e7744709 autoimmunehow to digital marketing strategy implementation practice pdf 7e7744709 for Repaglinide (Prandin)

Metabolized through CYP3A4

$$$

digital marketing strategy implementation practice pdf 7e7744709 genetic (🔴 levels) | digital marketing strategy implementation practice pdf 7e7744709 fastinghow to digital marketing strategy implementation practice pdf 7e7744709 for

Thiazolidinediones

Pioglitazone (Actos) Rosiglitazone (Avandia)

Weight gain; fluid retention

Hepatic disease; alanine transaminase level > 2.5 times normal; pregnancy; congestive heart failure (New York Heart Association class III or IV); use with caution in patients with edema

Association between rosiglitazone and cardiovascular events12,13

$$$$


CYP = cytochrome P450; NA = not applicable.

*— Relative cost is based on average wholesale price for one-month supply; range of cost of all diabetic agents divided into quartiles ($ = lowest cost, $$$$ = highest cost).

† — Generic available.

digital marketing strategy implementation practice pdf 7e7744709 occurs when (☑ options) | digital marketing strategy implementation practice pdf 7e7744709 treatment without medicationhow to digital marketing strategy implementation practice pdf 7e7744709 for ‡ — Not yet approved by the U.S Food and Drug Administration.

digital marketing strategy implementation practice pdf 7e7744709 overweight (⭐️ go away) | digital marketing strategy implementation practice pdf 7e7744709 juvenilehow to digital marketing strategy implementation practice pdf 7e7744709 for § — Brand no longer available in the United States.

digital marketing strategy implementation practice pdf 7e7744709 carbs allowed per day (🔴 lifestyle) | digital marketing strategy implementation practice pdf 7e7744709 diethow to digital marketing strategy implementation practice pdf 7e7744709 for Information from references 11 through 13.Information from references 11 through 13.

Table 2.

Medications Used to Manage Blood Glucose in Patients with Type 2 Diabetes Mellitus

digital marketing strategy implementation practice pdf 7e7744709 diagnostic procedures (🔴 questions and answers) | digital marketing strategy implementation practice pdf 7e7744709 common complicationshow to digital marketing strategy implementation practice pdf 7e7744709 for ClassDrugDrugPotential side effectsContraindicationsCommentsCommentsRelative for 1 last update 06 Jun 2020 cost*Relative cost*

Alpha glucosidase inhibitors

digital marketing strategy implementation practice pdf 7e7744709 with hyperglycemia icd 10 (⭐️ carbs allowed per day) | digital marketing strategy implementation practice pdf 7e7744709 vitamin dhow to digital marketing strategy implementation practice pdf 7e7744709 for Acarbose (Precose) the 1 last update 06 Jun 2020 Miglitol (Glyset)

Flatulence; abdominal pain; diarrhea

digital marketing strategy implementation practice pdf 7e7744709 youth (🔴 metformin) | digital marketing strategy implementation practice pdf 7e7744709 ominous octethow to digital marketing strategy implementation practice pdf 7e7744709 for —

To reverse hypoglycemia (usually only in setting of combination therapy), treat with oral glucose, not sucrose

$$

digital marketing strategy implementation practice pdf 7e7744709 treatment and prevention (☑ normal) | digital marketing strategy implementation practice pdf 7e7744709 journal articleshow to digital marketing strategy implementation practice pdf 7e7744709 for Amylin analogues

for 1 last update 06 Jun 2020 Pramlintide (Symlin)Pramlintide (Symlin)

Nausea and vomiting; anorexia; headache

Gastroparesis; lack of awareness of hypoglycemia; A1C > 9 percent

Severe hypoglycemia can occur, especially with coadministration of insulin; injectable medication; reduce insulin dose by 50 percent when initiating therapy

for 1 last update 06 Jun 2020 $$$$

digital marketing strategy implementation practice pdf 7e7744709 yoga (👍 values) | digital marketing strategy implementation practice pdf 7e7744709 chartshow to digital marketing strategy implementation practice pdf 7e7744709 for Biguanides

Metformin (Glucophage)

Nausea; diarrhea; flatulence

digital marketing strategy implementation practice pdf 7e7744709 guidelines (⭐️ doctor near me) | digital marketing strategy implementation practice pdf 7e7744709 is characterized ashow to digital marketing strategy implementation practice pdf 7e7744709 for Renal insufficiency (discontinue if creatinine level ≥ 1.4 in women or ≥ 1.5 in men); conditions that predispose to acidosis (e.g., liver disease, hypoxemia, sepsis); discontinue during acute illness and before radiographic procedures requiring intravenous dye (may restart 48 hours after procedure if serum creatinine levels are unchanged)

Decreases circulating androgen levels and increases rates of ovulation in women with polycystic ovarian syndrome; modest weight loss may occur; pregnancy category B based on animal studies but not well-studied in pregnant women

$†

Incretin enhancers

Saxagliptin (Onglyza)‡ Sitagliptin (Januvia)

Nausea and vomiting

Adjust dosage in patients with renal impairment

NA

Incretin mimetics

Exenatide (Byetta)

Nausea and for 1 last update 06 Jun 2020 vomiting; diarrhea; dizzinessNausea and vomiting; diarrhea; dizziness

Not recommended in patients with severe renal disease (creatinine clearance < 30 mL per for 1 last update 06 Jun 2020 minute)Not recommended in patients with severe renal disease (creatinine clearance < 30 mL per minute)

Injectable medication; modest weight loss may occur

digital marketing strategy implementation practice pdf 7e7744709 occur (🔴 carbs allowed per day) | digital marketing strategy implementation practice pdf 7e7744709 therapyhow to digital marketing strategy implementation practice pdf 7e7744709 for $$$$

Insulin secretagogues: sulfonylureas

Chlorpropamide (Diabinese)§

Hypoglycemia; weight gaindigital marketing strategy implementation practice pdf 7e7744709 kidney pain (👍 icd 10) | digital marketing strategy implementation practice pdf 7e7744709 pancreashow to digital marketing strategy implementation practice pdf 7e7744709 for Glimepiride (Amaryl) Glipizide (Glucotrol) Glyburide (Micronase)digital marketing strategy implementation practice pdf 7e7744709 and obesity (⭐️ treatment options) | digital marketing strategy implementation practice pdf 7e7744709 brochurehow to digital marketing strategy implementation practice pdf 7e7744709 for Tolazamide (Tolinase)§ Tolbutamide (Orinase)§

$†

the 1 last update 06 Jun 2020

the 1 last update 06 Jun 2020

the 1 last update 06 Jun 2020

Insulin secretagogues: nonsulfonylureas

Nateglinide (Starlix)

Hypoglycemia Repaglinide (Prandin)Hypoglycemia Repaglinide (Prandin)

Metabolized through CYP3A4

$$$

digital marketing strategy implementation practice pdf 7e7744709 natural diet recommendations (⭐️ with keto) | digital marketing strategy implementation practice pdf 7e7744709 with hyperglycemiahow to digital marketing strategy implementation practice pdf 7e7744709 for

Thiazolidinediones

Pioglitazone (Actos) Rosiglitazone (Avandia)

digital marketing strategy implementation practice pdf 7e7744709 treatment without medication (👍 kidney failure) | digital marketing strategy implementation practice pdf 7e7744709 genetichow to digital marketing strategy implementation practice pdf 7e7744709 for Weight gain; fluid retention

Hepatic disease; alanine transaminase level > 2.5 times normal; pregnancy; congestive heart failure (New York Heart Association class III or IV); use with caution in patients with edema

digital marketing strategy implementation practice pdf 7e7744709 blood test (☑ diet plan lose weight) | digital marketing strategy implementation practice pdf 7e7744709 testhow to digital marketing strategy implementation practice pdf 7e7744709 for Association between rosiglitazone and cardiovascular events12,13

$$$$


CYP = cytochrome P450; NA = not applicable.

*— Relative cost is based on average wholesale price for one-month supply; range of cost of all diabetic agents divided into quartiles ($ = lowest cost, $$$$ = highest cost).

digital marketing strategy implementation practice pdf 7e7744709 other names (☑ hands) | digital marketing strategy implementation practice pdf 7e7744709 quick factshow to digital marketing strategy implementation practice pdf 7e7744709 for † — Generic available.

‡ — Not for 1 last update 06 Jun 2020 yet approved by the U.S Food and Drug Administration.‡ — Not yet approved by the U.S Food and Drug Administration.

§ — Brand no longer available in the United States.

Information from references 11 through 13Information from references 11 through 13.

Insulin Secretagogues

Sulfonuylurea insulin secretagogues (e.g., glipizide [Glucotrol], glimepiride [Amaryl]) and nonsulfonylurea insulin secretagogues (e.g. nateglinide [Starlix]) increase insulin secretion by closing potassium channels on the surface of pancreatic beta cells.11 Hypoglycemia can occur with any insulin secretagogue. Sulfonylureas can cause weight gain; this effect is less common with nonsulfonylurea secretagogues. A recent review concluded that cardiovascular disease events are neither increased nor decreased with the use of sulfonylureas.17 There is insufficient evidence to make any conclusions about the effects of nonsulfonylurea secretagogues on cardiovascular morbidity and mortality.17

Biguanides

Metformin decreases hepatic glucose output and, to a lesser extent, sensitizes peripheral tissues to insulin.11 A review representing more than 36,000 patient-years of metformin use found no increase in fatal or nonfatal lactic acidosis.18 However, current guidelines recommend that metformin should not be used in patients with chronic or acute renal insufficiency, and should be discontinued when creatinine levels reach 1.4 mg per dL (120 μmol per L) in women or 1.5 mg per dL (130 μmol per L) in men. Metformin has been shown to decrease progression from impaired glucose tolerance to type 2 diabetes.6 To prevent one new case in three years, 13.9 persons would have to be treated with metformin.6 It is the only hypoglycemic agent shown to reduce mortality rates in patients with type 2 diabetes.5

digital marketing strategy implementation practice pdf 7e7744709 pills (⭐️ what is it) | digital marketing strategy implementation practice pdf 7e7744709 carb counthow to digital marketing strategy implementation practice pdf 7e7744709 for Thiazolidinediones

Thiazolidinediones increase insulin sensitivity in peripheral tissues and, to a lesser extent, decrease hepatic glucose production.11 These agents will not cause hypoglycemia when used as monotherapy. A recent review of 18 trials concluded that rosiglitazone (Avandia) is associated with an increased risk of myocardial infarction (MI) and death from cardiovascular causes.12 Another review of four trials concluded that the risk of MI and heart failure are significantly increased, but overall cardiovascular mortality rates are unaffected.13 The latter review was limited to trials with one or more years of follow-up, whereas the former review included trials with shorter follow-up periods. In a meta-analysis of 19 controlled trials, pioglitazone (Actos) was associated with a reduction in a composite end point of death, MI, and stroke.19 The incidence of serious heart failure was increased by 40 percent, but there was no change in cardiovascular disease mortality rates.

Alpha-Glucosidase Inhibitors

Alpha-glucosidase inhibitors act at the brush border in the small intestine, inactivating the enzyme that breaks down complex carbohydrates, slowing absorption, and flattening the postprandial glycemic curve.11 Acarbose (Precose) reduces the risk of cardiovascular disease events, including acute MI, in patients with impaired glucose tolerance or type 2 diabetes.17,20 for 1 last update 06 Jun 2020 ,,21

Incretin Mimetics and Incretin Enhancers

Incretin hormones stimulate glucose-dependent insulin secretion, decrease glucagon secretion, slow gastric emptying, and decrease appetite.11 Exenatide lowers blood glucose levels and stimulates weight loss, perhaps by slowing gastric emptying and producing satiety.11,22 Sitagliptin (Januvia) has no effect on body weight.23 There are no data on the effects of these medications on cardiovascular events.17

Amylin Analogues

Pramlintide is an amylin analogue indicated for use in patients with type 1 diabetes; it is rarely used the 1 last update 06 Jun 2020 to manage type 2 diabetes.11 When pramlintide is initiated, the insulin dosage should be reduced by 50 percent to avoid potentially severe hypoglycemia. There is insufficient evidence to make conclusions about the effects of pramlintide on cardiovascular disease.17Pramlintide is an amylin analogue indicated for use in patients with type 1 diabetes; it is rarely used to manage type 2 diabetes.11 When pramlintide is initiated, the insulin dosage should be reduced by 50 percent to avoid potentially severe hypoglycemia. There is insufficient evidence to make conclusions about the effects of pramlintide on cardiovascular disease.17

Approach to the Patient

Algorithms for the management of blood glucose contain elements derived from large, well-designed clinical trials, but the algorithms themselves are compiled from expert opinion and have not been conclusively evaluated14 for 1 last update 06 Jun 2020 ,,24 (Figure for 1 last update 06 Jun 2020 1Figure 1).7,14,24 The goal is to maintain blood glucose levels as close to normal as possible without risking significant hypoglycemia. The American Diabetes Association recommends an A1C goal of less than 7 percent.7 Glycemic control requires the patient to have cognitive, visual, and motor skills to monitor and manage blood glucose levels, and identifying and minimizing barriers for effective self-management is an important first step to setting individualized goals. There are no evidence-based recommendations for the frequency of home blood glucose monitoring except for patients administering multiple daily injections of insulin; several studies have questioned the usefulness of home monitoring.25,26 In patients with relatively well-controlled diabetes, home monitoring has not been associated with clinically significant improvements in A1C levels.25,26 Monitoring can be a useful tool in adjusting medications in the three-month intervals between A1C measurement, but it is also expensive and time-consuming, and it should be individualized to meet the needs of each patient.

View/Print Figure

Approach to the Patient with Type 2 Diabetes Mellitus

digital marketing strategy implementation practice pdf 7e7744709 new zealand (☑ webmd) | digital marketing strategy implementation practice pdf 7e7744709 icd 10how to digital marketing strategy implementation practice pdf 7e7744709 for Figure 1.

Algorithm for management of type 2 diabetes mellitus.

digital marketing strategy implementation practice pdf 7e7744709 urination (🔥 korean) | digital marketing strategy implementation practice pdf 7e7744709 leg painhow to digital marketing strategy implementation practice pdf 7e7744709 for Information from references 7,14, and 24.

Approach to the Patient with Type 2 Diabetes Mellitus


Figure 1.

Algorithm for management of type 2 diabetes mellitus.

Information from references 7,14, and 24.

INITIAL MANAGEMENT

The first step in managing type 2 diabetes is to normalize fasting glucose levels, with weekly or monthly adjustments in the regimen.14 Metformin is a first-line consideration. Gastrointestinal symptoms associated with its use can be minimized by beginning with a low dose and titrating slowly. Additional agents include sulfonylureas, nonsulfonylurea secretagogues, thiazolidinediones, and alpha-glucosidase inhibitors. Any of these agents can be combined with another. Once fasting blood glucose approaches near-normal levels, postprandial glucose is addressed by increasing the dose of the current medications or by adding additional agents. Once maximal benefit is achieved from first-line medications, other agents, such as exenatide (approved the 1 last update 06 Jun 2020 for use with metformin or sulfonylureas) and sitagliptin (approved for use with metformin or thiazolidinediones), can be considered.The first step in managing type 2 diabetes is to normalize fasting glucose levels, with weekly or monthly adjustments in the regimen.14 Metformin is a first-line consideration. Gastrointestinal symptoms associated with its use can be minimized by beginning with a low dose and titrating slowly. Additional agents include sulfonylureas, nonsulfonylurea secretagogues, thiazolidinediones, and alpha-glucosidase inhibitors. Any of these agents can be combined with another. Once fasting blood glucose approaches near-normal levels, postprandial glucose is addressed by increasing the dose of the current medications or by adding additional agents. Once maximal benefit is achieved from first-line medications, other agents, such as exenatide (approved for use with metformin or sulfonylureas) and sitagliptin (approved for use with metformin or thiazolidinediones), can be considered.

INITIATING INSULIN THERAPY

Less than 40 percent of patients with diabetes successfully achieve an A1C level of less than 7 percent.24 One reason for this is the reluctance of patients and physicians to start insulin therapy, perceiving it as a treatment failure. However, progressive failure of the beta cells often occurs even with proper diet, exercise, and oral medications, so patients should be counseled that insulin is simply another management tool. Although insulin is typically introduced when glucose control is no longer possible with oral agents, it can also be used when contraindications to oral medications exist. Newly diagnosed patients also can benefit from acute insulin use. Prolonged hyperglycemia can cause glucose toxicity, a potentially reversible impairment in glucose-stimulated insulin secretion. This can be corrected with aggressive insulin therapy, then oral medications can be added as insulin is tapered or discontinued. Expert opinion suggests that insulin therapy should be initiated if the fasting blood glucose level is consistently greater than 250 mg per dL (13.90 mmol per L), or if random testing shows levels greater than 300 mg per dL24 (16.65 mmol per L; digital marketing strategy implementation practice pdf 7e7744709 treatment aafp (☑ ketosis) | digital marketing strategy implementation practice pdf 7e7744709 case studyhow to digital marketing strategy implementation practice pdf 7e7744709 for Figure 1Figure 17 the 1 last update 06 Jun 2020 ,,14,24).

When adding insulin to an oral medication regimen, oral agents should initially be continued. Long-acting insulin should be used initially, typically at a dosage of 10 units per day or 0.17 to 0.5 units per kg per day, and titrated in increments of two units approximately every three days14 the 1 last update 06 Jun 2020 ,,24  (Table 3). Rapid-acting or premixed preparations can be added if fasting blood glucose levels are persistently high or if A1C has plateaued at about 7.5 percent, which indicates that postprandial glucose levels are high. Adding more basal insulin in this setting usually will not help patients reach their target levels.24 Sliding-scale doses can be set by counting carbohydrate grams or by a preset scale (Figure 2). For the latter method, one suggested regimen is to give 90 percent of the basal dose of insulin in long-acting form and the remainder in rapid-acting form at the largest meal, then adjust the dose as necessary.24 Insulin is used almost exclusively in pregnancy because of the concern of teratogenicity with oral medications.

View/Print Table

Table 3.

Insulin and Insulin Analogues

Insulin preparationdigital marketing strategy implementation practice pdf 7e7744709 treatments lexington (🔴 obese) | digital marketing strategy implementation practice pdf 7e7744709 fruithow to digital marketing strategy implementation practice pdf 7e7744709 for Onset for 1 last update 06 Jun 2020 of actionOnset of actionPeakDuration of for 1 last update 06 Jun 2020 actionDuration of actiondigital marketing strategy implementation practice pdf 7e7744709 with mellitus (⭐️ with weight loss) | digital marketing strategy implementation practice pdf 7e7744709 kidneyhow to digital marketing strategy implementation practice pdf 7e7744709 for for 1 last update 06 Jun 2020 CommentsComments

Rapid-acting insulin

Lispro (Humalog)

5 to 15 minutes

1 to 2 hours

4 to 5 for 1 last update 06 Jun 2020 hours4 to 5 hours

Aspart (Novolog)

5 to 15 minutes

1 to 2 hours

4 to 5 hours

Glulisine (Apidra)

5 to 15 minutes

1 to 2 hours

4 to 5 hours

Regular (recombinant) (Humulin for 1 last update 06 Jun 2020 R)Regular (recombinant) (Humulin R)

30 to 60 minutes

2 to 4 hours

8 to 10 hours

Inject 30 minutes before meal

Intermediate-acting insulin

Isophane (NPH) (Humulin the 1 last update 06 Jun 2020 N) Long-acting insulinIsophane (NPH) (Humulin N) Long-acting insulin

digital marketing strategy implementation practice pdf 7e7744709 ankle swelling (☑ tools) | digital marketing strategy implementation practice pdf 7e7744709 oatmealhow to digital marketing strategy implementation practice pdf 7e7744709 for 1 to 2 hours

4 to 8 hours

10 to 20 hours

Detemir (recombinant) (Levemir)

1 to 2 hours

Relatively flat

12 to 20 hours

Smoother curve than NPH; administered once or twice daily; available in pen form; can be kept without refrigeration for up to 42 days

Glargine (Lantus)

1 to 2 hours

Relatively flat

20 to 24 hours

Available in pen form

Mixed insulin

Multiple preparations (e.g., Humulin 70/30)

30 the 1 last update 06 Jun 2020 minutes30 minutes

Dual peak

Up to 24 hours

Mixed insulin preparations may hinder tight glycemic control because the ratio of the two preparations cannot be altered

Table 3.

Insulin and Insulin Analogues

Insulin preparationOnset of actiondigital marketing strategy implementation practice pdf 7e7744709 drugs (⭐️ questionnaire tool) | digital marketing strategy implementation practice pdf 7e7744709 ketosishow to digital marketing strategy implementation practice pdf 7e7744709 for PeakDuration for 1 last update 06 Jun 2020 of actionDuration of actionComments

Rapid-acting insulin

Lispro (Humalog)

digital marketing strategy implementation practice pdf 7e7744709 korean (⭐️ in youth) | digital marketing strategy implementation practice pdf 7e7744709 jewelryhow to digital marketing strategy implementation practice pdf 7e7744709 for 5 to 15 minutes

1 to 2 hours

4 to 5 hours

Aspart (Novolog)

5 to 15 minutes

1 to 2 hours

4 to 5 hours

Glulisine (Apidra)

5 to 15 minutes

1 to the 1 last update 06 Jun 2020 2 hours1 to 2 hours

4 to 5 hours

the 1 last update 06 Jun 2020 ——

Regular (recombinant) (Humulin R)

30 to 60 minutes

2 to for 1 last update 06 Jun 2020 4 hours2 to 4 hours

8 to 10 hours

Inject 30 minutes before meal

Intermediate-acting the 1 last update 06 Jun 2020 insulinIntermediate-acting insulin

Isophane (NPH) (Humulin N) Long-acting insulin

1 to 2 hours

4 to 8 the 1 last update 06 Jun 2020 hours4 to 8 hours

10 to 20 hours

Detemir (recombinant) (Levemir)

1 to 2 hours

Relatively flat

12 to 20 hours

Smoother curve than NPH; administered once or twice daily; available in pen form; can be kept for 1 last update 06 Jun 2020 without refrigeration for up to 42 daysSmoother curve than NPH; administered once or twice daily; available in pen form; can be kept without refrigeration for up to 42 days

Glargine (Lantus)

1 to 2 hours

Relatively flat

20 to 24 hours

Available in pen form

Mixed insulin

Multiple preparations (e.g., Humulin 70/30)

30 minutes

Dual peak

Up to 24 hours

Mixed insulin preparations may hinder tight glycemic control because the ratio of the two preparations cannot be altered

digital marketing strategy implementation practice pdf 7e7744709 soda (👍 definition) | digital marketing strategy implementation practice pdf 7e7744709 would be consideredhow to digital marketing strategy implementation practice pdf 7e7744709 for View/Print Figure

Creating a Sliding-Scale Insulin Regimen

digital marketing strategy implementation practice pdf 7e7744709 journal (⭐️ treatments google search) | digital marketing strategy implementation practice pdf 7e7744709 range charthow to digital marketing strategy implementation practice pdf 7e7744709 for Figure 2.

Steps to create a sliding scale for the use of rapid-acting insulin. (CF = correction factor; C:I = carbohydrate-to-insulin ratio; TDDI = total daily dose of insulin.)

Creating a Sliding-Scale Insulin Regimen


Figure 2.

Steps to create a sliding scale for the use of rapid-acting insulin. (CF = correction factor; C:I = carbohydrate-to-insulin ratio; TDDI = total daily dose of insulin.)

CHILDREN AND OLDER ADULTS

digital marketing strategy implementation practice pdf 7e7744709 patch (👍 jardiance) | digital marketing strategy implementation practice pdf 7e7744709 mellitushow to digital marketing strategy implementation practice pdf 7e7744709 for As the prevalence of obesity in children has increased, type 2 diabetes has also become more common. Metformin is approved for use in children 10 years and older and sustained-release preparations are approved for use in persons 17 years and older who cannot maintain glycemic control with diet and exercise.7,27

The increased prevalence of comorbid conditions in older adults requires careful consideration of medications. Serum creatinine levels are not always a reliable predictor of renal insufficiency in the elderly, so metformin should be used with caution. The high prevalence of heart failure in this population limits the use of thiazolidinediones. Older patients are likely to benefit more from aggressive management of known cardiovascular disease risk factors such as hypertension than by tight glycemic control, which can increase symptomatic hypoglycemia.7

digital marketing strategy implementation practice pdf 7e7744709 born (⭐️ origin) | digital marketing strategy implementation practice pdf 7e7744709 kidney failurehow to digital marketing strategy implementation practice pdf 7e7744709 for Read the full article.

  • Get immediate access, anytime, anywhere.
  • Choose a single article, issue, or full-access subscription.
  • Earn up to 6 CME credits per issue.
Already a member/subscriber?

Log in >>

Already a member or subscriber? Log in

digital marketing strategy implementation practice pdf 7e7744709 in hindi (🔴 paper) | digital marketing strategy implementation practice pdf 7e7744709 educationhow to digital marketing strategy implementation practice pdf 7e7744709 for  

digital marketing strategy implementation practice pdf 7e7744709 and urine (🔴 herpes) | digital marketing strategy implementation practice pdf 7e7744709 yeast infectionshow to digital marketing strategy implementation practice pdf 7e7744709 for Best for 1 last update 06 Jun 2020 Value!Best Value!

Get Full Access

From $140

  • Includes:
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits per year
  • Access to the AFP app
  • Print delivery option

 

digital marketing strategy implementation practice pdf 7e7744709 mellitus icd 10 (🔴 ketone) | digital marketing strategy implementation practice pdf 7e7744709 mellitus nature reviews disease primershow to digital marketing strategy implementation practice pdf 7e7744709 for Access This Issue

$39.95

 
  • Includes:
  • Immediate access to this issue
  •   CME credits in this issue

 

Access This Article

$20.95

 
  • Includes:
  • Immediate access to this article

 
 
To see the full article, log in or purchase access.

The Authors

show all author info

CYNTHIA M. RIPSIN, MD, MS, MPH, is an assistant professor of family medicine at the University of Texas Medical Branch in Galveston. She received her medical degree from Eastern Virginia Medical School, Nor-folk, and her master''s The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2005.

12. Singh S, Loke YK, Furberg CD. Long-term for 1 last update 06 Jun 2020 risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA. 2007;298(10):1189–1195.12. Singh S, Loke YK, Furberg CD. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA. 2007;298(10):1189–1195.

13. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes [published correction appears in N Engl J Med. 2007;357(1):100]. N Engl J Med. 2007;356(24):2457–2471.

14. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy [published correction appears in Diabetes Care. 2006;49(11):2816–2818]. Diabetes Care. 2006;29(8):1963–1972.

15. Kimmel B, Inzucchi SE. Oral agents for type 2 diabetes: an update. Clin Diabetes. 2006;23:64–76.

16. Bolen S, Feldman L, Vassy J, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus [published correction appears in Ann Intern Med. 2007;147(12):887]. Ann Intern Med. 2007;147(6):386–399.

17. Uwaifo GI, Ratner RE. Differential effects of oral hypoglycemic agents on glucose control and cardiovascular risk. Am J Cardiol. 2007;99(4A):51B–67B.

18. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med. 2003;163(21):2594–2602.

19. Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA. 2007;298(10):1180–1188.

20. Chiasson JL. Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the STOP-NIDDM Trial. Endocr Pract. 2006;12(suppl 1):25–30.20. Chiasson JL. Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the STOP-NIDDM Trial. Endocr Pract. 2006;12(suppl 1):25–30.

digital marketing strategy implementation practice pdf 7e7744709 events (🔴 Treatments) | digital marketing strategy implementation practice pdf 7e7744709 dinnerhow to digital marketing strategy implementation practice pdf 7e7744709 for 21. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laasko M, for the STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. JAMA. 2003;290(4):486–494.

22. AHFS Drug Information. Exenatide (systemic). http://www.ashp.org/mngrphs/essentials/a305021e.htm. Accessed October 9, 2008.

23. AHFS Drug Information. Sitagliptin phosphate. http://www.ashp.org/mngrphs/AHFS/a307001.htm. Accessed October the 1 last update 06 Jun 2020 9, 2008.23. AHFS Drug Information. Sitagliptin phosphate. http://www.ashp.org/mngrphs/AHFS/a307001.htm. Accessed October 9, 2008.

24. Hirsch IB, Bergenstal RM, Parkin CG, Wright E Jr, Buse JB. A real-world approach to insulin therapy in primary care practice. Clin Diabetes. 2005;23:78–86.

digital marketing strategy implementation practice pdf 7e7744709 ncbi (🔴 natural medications) | digital marketing strategy implementation practice pdf 7e7744709 long term effectshow to digital marketing strategy implementation practice pdf 7e7744709 for 25. Farmer A, Wade A, Goyder E, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ. 2007;335(7611):132

26. digital marketing strategy implementation practice pdf 7e7744709 is caused by (👍 treatment options) | digital marketing strategy implementation practice pdf 7e7744709 yogurthow to digital marketing strategy implementation practice pdf 7e7744709 for Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care. 2005;28(6):1510–1517.

digital marketing strategy implementation practice pdf 7e7744709 joint pain (🔴 mellitus definition) | digital marketing strategy implementation practice pdf 7e7744709 hypoglycemiahow to digital marketing strategy implementation practice pdf 7e7744709 for 27. AHFS Drug Information. Metformin hydrochloride. http://www.ashp.org/mngrphs/AHFS/a396005.htm. Accessed October 9, 2008.

 

 

Copyright © 2009 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact [email protected] for copyright questions and/or permission requests.

  • SHARE

Want to use this article elsewhere? Get Permissions

Advertisement

More in AFP


digital marketing strategy implementation practice pdf 7e7744709 lunch (👍 and pregnancy) | digital marketing strategy implementation practice pdf 7e7744709 genehow to digital marketing strategy implementation practice pdf 7e7744709 for Editor''t miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article


Continue reading from January 1, 2009

Previous: Keeping Up with the Medical Literature: How to Set Up a System

Next: Soy: A Complete Source of Protein

View the full table of contents >>

Home / Journals digital marketing strategy implementation practice pdf 7e7744709 with diet (☑ juvenile) | digital marketing strategy implementation practice pdf 7e7744709 youthhow to digital marketing strategy implementation practice pdf 7e7744709 for / afp the 1 last update 06 Jun 2020 // Vol. 79/No. 1(January 1, 2009) / Management of Blood Glucose in Type 2 Diabetes Mellitus